PCI术后FFR改善与症状缓解及结局的关联
该研究为FAME 1和FAME 2试验的事后分析,纳入639例患者837处病变,按ΔFFR三分位分组。结果显示ΔFFR最低组(≤0.18)2年血管导向临床事件发生率显著高于最高组(>0.31)(9.1% vs 4.7%;HR 2.01;
要点
- PCI术后FFR改善幅度越大,2年血管导向临床事件发生率越低。
- ΔFFR最低三分位组事件风险是最高组的2.01倍(95%CI 1.03-3.92)。
- ΔFFR与术后症状缓解独立相关(OR 1.33;95%CI 1.02-1.74)。
核心结论
- PCI术后FFR改善越大,症状缓解越明显且2年事件率越低。
- PCI前后测量FFR可提供有临床价值的信息。
研究设计与样本
- FAME 1和FAME 2随机临床试验的事后分析,纳入2年随访数据。
- 分析639例患者837处病变,均有PCI前后FFR值。
- FAME 1纳入欧洲和美国20个中心的多支冠状动脉病变患者;FAME 2纳入欧洲和北美28个中心的稳定冠心病(最多3支血管病变)患者。
主要发现
- ΔFFR中间三分位组(0.19-0.31)事件率未在摘要中报告。
关键数值与推荐
- ΔFFR三分位分组:最低≤0.18(277处病变),中间0.19-0.31(282处病变),最高>0.31(278处病变)。
临床怎么用
- PCI前后测量FFR可评估血运重建的生理获益,ΔFFR较小提示事件风险较高。
- ΔFFR可作为术后症状缓解和2年预后的参考指标。
局限性
- 本研究为随机试验的事后分析,非预设主要终点。
- 仅纳入有PCI前后FFR数据的病变,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Whether the improvement in myocardial perfusion provided by percutaneous coronary intervention (PCI) is associated with symptomatic relief or improved outcomes has not been well investigated. OBJECTIVE: To investigate the prognostic value of the improvement in fractional flow reserve (FFR) after PCI (ΔFFR) on patients' symptoms and 2-year outcomes. DESIGN, SETTING, AND PARTICIPANTS: This study is a post hoc analysis of data from patients undergoing FFR-guided PCI in the randomized clinical trials Fractional Flow Reserve vs Angiography for Multivessel Evaluation (FAME) 1 (NCT00267774; 2009) and FAME 2 (NCT01132495; 2012), with inclusion of 2 years of follow-up data. The FAME 1 trial included patients with multivessel coronary artery disease from 20 medical centers in Europe and the United States. The FAME 2 trial included patients with stable coronary artery disease involving up to 3 vessels from 28 sites in Europe and North America. Lesions from the group in the FAME 1 trial from whom FFR was measured and the group in the FAME 2 trial who received FFR-guided PCI plus medical therapy were analyzed. Data analysis occurred from May 2017 to May 2018. INTERVENTIONS: Measure of post-PCI FFR. MAIN OUTCOMES AND MEASURES: Vessel-oriented clinical events at 2 years, a composite of cardiac death, target vessel-associated myocardial infarction, and target vessel revascularization. RESULTS: This analysis included 639 patients from whom pre-PCI and post-PCI FFR values were available. Of their 837 lesions, 277 were classified into the lowest tertile (ΔFFR≤0.18), 282 into the middle tertile (0.19≤ΔFFR≤0.31), and 278 into the highest tertile (ΔFFR>0.31). Vessel-oriented clinical events were significantly more frequent in the lowest tertile (n = 25 of 277 [9.1%]) compared with the highest tertile (n = 13 of 278 [4.7%]; hazard ratio, 2.01 [95% CI, 1.03-3.92]; P = .04). In addition, a significant association was observed between ΔFFR and symptomatic relief (odds ratio, 1.33 [95% CI, 1.02-1.74]; P = .02). CONCLUSIONS AND RELEVANCE: In this analysis of 2 randomized clinical trials, the larger the improvement in FFR, the larger the symptomatic relief and the lower the event rate. This suggests that measuring FFR before and after PCI provides clinically useful information.
引用
- Fournier S, Ciccarelli G, Toth GG, et al. Association of Improvement in Fractional Flow Reserve With Outcomes, Including Symptomatic Relief, After Percutaneous Coronary Intervention. JAMA Cardiol. 2019. PMID: 30840026. doi:10.1001/jamacardio.2019.0175
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。